Skip to content
10-Q

Quarterly Report

AXIM BIOTECHNOLOGIES, INC. AXIM

0001096906-24-001202

← back to feed
Filed
May 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.01
Eps Basic Q1 2024 · Mar 31, 2023 −$0.01
Sga Expense Q1 2024 · Mar 31, 2023 $590.94K
Rd Expense Q1 2024 · Mar 31, 2023 $20.34K
Net Income Q1 2024 · Mar 31, 2023 −$2.76M
Operating Income Q1 2024 · Mar 31, 2023 −$710.63K
Revenue Q1 2024 · Mar 31, 2023 $7.4K